Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of Intensity-Modulated or Proton Radiation Therapy for Locally Advanced Sinonasal Malignancy

NCT01586767 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT01586767
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01586767 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of Intensity-Modulated or Proton Radiation Therapy for Locally Advanced Sinonasal Malignancy
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
July 12, 2011
Completion date
November 30, 2025
Enrollment
45 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenoid cystic carcinoma, esthesioneuroblastoma, melanoma, mucoepidermoid carcinoma, myoepithelial carcinoma, schneiderian carcinoma, sinonasal carcinoma, sinonasal undifferentiated carcinoma, squamous cell carcinoma